Idorsia to advance cenerimod into Phase 3 development for treatment of patients with systemic lupus erythematosus

NEXT STORY
Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November
PREV STORY
HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New to The Street / Newsmax TV Announces 8 Interviews for this Week’s TV Broadcast, October 3, 2021, airing at 10-11 AM ET

author_avatar
NASDAQ Market News

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Advaxis Stockholders Vote “FOR” Proposed Merger with Biosight

author_avatar
NASDAQ Market News

Anaesthesia & Respiratory Devices Market Size Report Up to 2030 : Visiongain Research, Inc.

author_avatar
NASDAQ Market News